Raynaud's phenomenon and scleroderma associated with silicone gel breast implants: An example of Asia syndrome

European Journal of Inflammation

Volumn 10, Issue 2, 2012, Pages 233-238

  Del Giacco, Stefano R ^a   Firinu, D ^a   Piludu, G ^a   Settembrini, A M ^a   Tulli, M ^a   Pirari, P ^a   Nalli, E ^a   Mura, M N ^a   Manconi, P E ^a   Del Giacco, G S ^a  

^a DEPARTMENT OF RADIOLOGY   (Italy)

Author keywords

Asia syndrome; Breast implants; Capillaroscopy; Raynaud's phenomenon; Scleroderma; Silicone; Systemic sclerosis

Indexed keywords

ILOPROST; PREDNISONE; SILICONE GEL;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE INFLAMMATORY SYNDROME INDUCED BY ADJUVANT; AUTOIMMUNE THYROIDITIS; BREAST AUGMENTATION; BREAST DISEASE; BREAST SWELLING; CASE REPORT; CONNECTIVE TISSUE DISEASE; CYANOSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE PREDISPOSITION; DYSPHAGIA; ECHOCARDIOGRAPHY; ECHOGRAPHY; ERYTHEMA; EXERCISE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HYPOTHERMIA; HYPOTHYROIDISM; IMMUNE SYSTEM; LUNG ARTERY PRESSURE; MICROCIRCULATION; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; REMISSION; RISK FACTOR; SCLERODERMA; SILICONE BREAST IMPLANT; SYSTEMIC SCLEROSIS; VITILIGO;

EID: 84867215828     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1201000209     Document Type: Article

References (22)

1. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15:202-5. (Pubitemid 18073738)
2. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27:155-60. (Pubitemid 30058643)
3. Kumagai Y, Shiokawa Y, Medsger TA, Jr, Rodnan GP. Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. Arthritis Rheum 1984; 27:1-12. (Pubitemid 14176530)
4. Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 2000; 342:781-90. (Pubitemid 30151922)
5. Gabriel SE, O'Fallon WM, Kurland LT, Beard CM, Woods JE, Melton LJ 3rd. Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 1994; 330:1697-702.
6. Karlson EW, Hankinson SE, Liang MH, et al. Association of silicone breast implants with immunologic abnormalities: a prospective study. Am J Med 1999; 106:11-19. (Pubitemid 29077137)
7. Lidar M, Agmon-Levin N, Langevitz P, Shoenfeld Y. Silicone and scleroderma revisited. Lupus 2012; 21:121-7.
8. Shoenfeld Y, Agmon-Levin N. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011; 36:4-8.
9. Prantl L, Poppl N, Horvat N, Heine N, Eisenmann-Klein M. Serologic and histologic findings in patients with capsular contracture after breast augmentation with smooth silicone gel implants: is serum hyaluronan a potential predictor? Aesthetic Plast Surg 2005; 29:510-18. (Pubitemid 43029784)
10. Brown SL, Pennello G, Berg WA, Soo MS, Middleton MS. Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women. J Rheumatol 2001; 28:996-1003. (Pubitemid 32422579)
11. Iannello S, Belfiore F. Silicone breast prosthesis and rheumatoid arthritis: a new systemic disease: siliconosis. A case report and a critical review of the literature. Minerva Med 1998; 89:117-30. (Pubitemid 28331292)
12. Bekerecioglu M, Onat AM, Tercan M, Buyukhatipoglu H, Karakok M, Isik D, Bulut O. The association between silicone implants and both antibodies and autoimmune diseases. Clin Rheumatol 2008; 27:147-50.
13. Zandman-Goddard G, Blank M, Ehrenfeld M, Gilburd B, Peter J, Shoenfeld Y. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. J Rheumatol 1999; 26:73-77. (Pubitemid 29051398)
14. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus 2009; 18:1217-25.
15. Otsuki T, Hayashi H, Nishimura Y, et al. Dysregulation of autoimmunity caused by silica exposure and alteration of Fas-mediated apoptosis in T lymphocytes derived from silicosis patients. Int J Immunopathol Pharmacol 2011; 24:11S-16S.
16. Schaefer CJ, Wooley PH. The influence of silicone implantation on murine lupus in MRL 1pr/1pr mice. J Rheumatol 1999; 26:2215-21. (Pubitemid 29487020)
17. Koenig M, Joyal F, Fritzler MJ, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008; 58:3902-12.
18. Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol 2010; 37:42-53.
19. Beretta L, Rueda B, Marchini M, et al. Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis. Rheumatology (Oxford) 2012; 51:52-59.
20. Ohyama H, Nishimura F, Meguro M, Takashiba S, Murayama Y, Matsushita S. Counter-antigen presentation: fibroblasts produce cytokines by signalling through HLA class II molecules without inducing T-cell proliferation. Cytokine 2002; 17:175-81.
21. Guis S, Pellissier JF, Nicoli F, et al. HLA-DRB1*01 and macrophagic myofasciitis. Arthritis Rheum 2002; 46:2535-37.
22. Barros SM, Carvalho JF. Shoenfeld's syndrome after pandemic influenza A/H1N1 vaccination. Acta Reumatol Port 2011; 36:65-68.